Top Stories

Published on Monday, May 9, 2016

COPD Foundation announces new leadership; Grace Anne Dorney Koppel named President and Craig Kephart becomes CEO

COPD Foundation announces new leadership; Grace Anne Dorney Koppel named President and Craig Kephart becomes CEO

The COPD Foundation, the only U.S. healthcare not-for-profit solely dedicated to preventing and curing chronic obstructive pulmonary disease (COPD) while working to improve therapies, today announced that Grace Anne Dorney Koppel has been named President of the Foundation, effective May 6, 2016. Craig Kephart, who had been serving as Acting President at the Foundation, has been named Chief Executive Officer.

Grace Anne Dorney Koppel

“I am delighted that Grace Anne has taken on this new position of President after having been such a valuable member and contributor to the COPD Foundation Board of Directors,” said Byron Thomashow, MD, chairman of the Board of Directors. “In addition to having a long history of patient advocacy, Grace Anne is a proven leader ready to tackle the issues facing the 30 million Americans affected by COPD. I am confident that with Grace Anne and Craig at the helm, the COPD Foundation will continue to build on the legacy started by Founder John Walsh over a decade ago. We remain hopeful that John will continue to recover and ultimately resume his important role at the Foundation.”

Dorney Koppel was diagnosed with COPD in July 2001, and since January 2006 she has served as the national spokeswoman and patient advocate for the National Heart, Lung, and Blood Institute to increase awareness of COPD. She has appeared on CBS Evening News, Good Morning America, The View, and other major media outlets. 

Dorney Koppel, a graduate of Fordham University (BA), Stanford University (MA), and Georgetown Law (JD), is a practicing attorney and business manager for her husband, former Nightline anchor Ted Koppel. She is president of the Dorney Koppel Foundation, which provides start-up funding and strategic guidance for pulmonary rehabilitation centers. She is also a current member of the COPD Foundation Board of Directors.

“No goal is more urgent than the development of a cure for COPD, but until such time, we have two interim goals that require the nation’s immediate attention and support: identifying the 12 to 15 million Americans who have COPD but don’t yet know it, and conveying to the overall population of 30 million COPD patients in America that it is still possible to continue living a useful and productive life until we find better treatments and a cure. Ours is a misunderstood and under-acknowledged disease. To the best of my abilities, I hope to bring COPD out from the shadows into the light of understanding and support which we desperately need,” Dorney Koppel said.


Powerful video raises awareness of COPD and the need for research funding

Monday, November 11, 2019
November is National Alpha-1 Awareness Month and is also National Chronic Obstructive Pulmonary Disease (COPD) Awareness Month, and a powerful new video has been released that raises awareness of the critical need for significantly increased COPD...

Alpha-1 Awareness Month 2019: Virtual Walks week 1 (recap)

Saturday, November 9, 2019
November represents Alpha-1 Awareness Month and the community has set the tone for the month in week one. Alphas, friends, and family joined together on November 2nd around the country in their purple shirts to spread awareness and raise funds for...

Grifols introduces AlphaID™, a free cheek swab to screen for Alpha-1, the most common genetic form of COPD

Friday, November 8, 2019
BARCELONA, Spain, Nov. 7, 2019 -- Grifols, a leading global producer of plasma-derived medicines and a leader in the development of innovative diagnostic solutions, has now introduced AlphaID™, a new, simple cheek swab that can be used...

November is Alpha-1 Awareness Month

Friday, November 1, 2019
Miami, Nov. 1, 2019 – The month of November has been declared as Alpha-1 Awareness Month, by the Alpha-1 Foundation, to raise awareness about Alpha-1 Antitrypsin Deficiency (Alpha-1) throughout the United States. During November, several...

Mark Brantly, MD: Interim Scientific Director of the Alpha-1 Foundation

Wednesday, October 23, 2019
Mark Brantly, MD, has been named interim scientific director of the Alpha-1 Foundation, as Adam Wanner, MD, announced his resignation after 13 years of service to the Alpha-1 Foundation and the Alpha-1 community. Wanner served as scientific...

Jonathan Maidment completes a thru-hike of the Pacific Crest Trail raising awareness and funds for Alpha-1

Wednesday, October 16, 2019
October 16, 2019 – Hiking the Pacific Crest Trail (PCT) for the past seven months. Jonathan Maidment completes his journey to raise awareness and funds for Alpha-1 Antitrypsin Deficiency (Alpha-1). Holding up his Alpha Angels flag to honor...

Medicare: Open Enrollment for 2020

Monday, October 14, 2019
Medicare Open Enrollment begins on October 15, 2019 and ends on December 7, 2019. During this time, Medicare beneficiaries can compare coverage options like Original Medicare and Medicare Advantage and choose health and drug plans for...

Medicare Part D: Smoothing the out-of-pocket cap

Thursday, October 10, 2019
The Medicare Prescription drug benefit, or Part D, is an optional program from the Federal Government that helps older adults pay for their prescription drugs. Under Part D, the government and the individual share the cost of drugs up to a certain...

Escape to the Cape 2019: Team Alpha-1 at its best

Sunday, October 6, 2019
Even though the bike trek started with heavy hearts due to the very recent passing of two amazing Alpha volunteers, Susan Binnall and Alyce Yout, Team Alpha-1 pushed through and dedicated the ride to them: “Alyce & Sue This Rides for...

Open for comments: FDA proposes new required health warnings for cigarette packages

Tuesday, September 24, 2019
The U.S. Food and Drug Administration (FDA) issued a proposed rule to require new health warnings on cigarette packages and advertisements to promote greater public understanding of the negative health consequences of smoking. The agency...

FDA/NIH public workshop: Developing Alpha-1 Antitrypsin Therapeutics

Tuesday, September 17, 2019
The Alpha-1 Foundation is proud and grateful for the opportunity to collaborate with the FDA, Center for Biologics Evaluation and Research (CBER), and the National Institutes of Health (NIH) in organizing the public workshop entitled...

White House prepares to ban flavored e-cigs

Tuesday, September 17, 2019
The Trump administration said it is planning to ban all e-cigarette flavors following a recent nationwide outbreak of severe lung illnesses linked to vaping and five reported deaths, according to pool reports. President Donald Trump told...

Article Search

Enter keywords in text box and click Search button for results.